CATALOGO DEI PRODOTTI DELLA RICERCA

CIPOLLI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.019
EU - Europa 1.894
AS - Asia 1.456
SA - Sud America 221
AF - Africa 43
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.638
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.973
RU - Federazione Russa 804
SG - Singapore 526
CN - Cina 464
GB - Regno Unito 373
IT - Italia 184
BR - Brasile 167
VN - Vietnam 165
HK - Hong Kong 109
SE - Svezia 99
DE - Germania 89
FR - Francia 87
IE - Irlanda 77
FI - Finlandia 72
KR - Corea 59
IN - India 27
CA - Canada 26
JP - Giappone 18
EC - Ecuador 17
ID - Indonesia 17
NL - Olanda 17
AR - Argentina 16
BE - Belgio 16
ES - Italia 16
BD - Bangladesh 15
MX - Messico 15
ZA - Sudafrica 15
PL - Polonia 13
UA - Ucraina 13
TR - Turchia 11
NG - Nigeria 9
AT - Austria 8
PK - Pakistan 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
IQ - Iraq 6
PY - Paraguay 6
BJ - Benin 5
CO - Colombia 5
AU - Australia 4
CH - Svizzera 4
LT - Lituania 4
MA - Marocco 4
CL - Cile 3
CZ - Repubblica Ceca 3
TG - Togo 3
BG - Bulgaria 2
BO - Bolivia 2
EG - Egitto 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
OM - Oman 2
PE - Perù 2
UY - Uruguay 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
VE - Venezuela 1
YT - Mayotte 1
Totale 5.638
Salva come PNG Salva come JPEG
Città #
Southend 303
Dallas 284
Moscow 275
Singapore 271
Ashburn 251
Chandler 248
San Jose 193
Beijing 107
Hong Kong 107
Woodbridge 91
Ann Arbor 87
Verona 85
Dublin 77
The Dalles 69
Jacksonville 58
New York 52
Ho Chi Minh City 50
Houston 44
Los Angeles 41
Helsinki 39
Hanoi 38
Nanjing 36
Munich 29
Lawrence 28
Princeton 28
Jinan 27
Shenyang 24
Seoul 23
Buffalo 22
Wilmington 22
Santa Clara 19
São Paulo 19
Council Bluffs 17
Tokyo 17
Milan 15
Brussels 14
Hebei 14
Amsterdam 13
Changsha 13
Dong Ket 11
Jakarta 11
Johannesburg 11
Montreal 11
Warsaw 11
Columbus 10
Denver 10
London 10
Redondo Beach 10
Taizhou 10
Turku 10
Abuja 9
Ankara 9
Bologna 9
Chennai 9
Nanchang 9
Ningbo 9
Stockholm 9
Boardman 8
Chicago 8
Frankfurt am Main 8
Haikou 8
Tianjin 8
Brooklyn 7
Orem 7
Sindelfingen 7
Tashkent 7
Zhengzhou 7
Falkenstein 6
Ferrara 6
Jiaxing 6
Norwalk 6
Quito 6
San Francisco 6
Seattle 6
Vienna 6
Asunción 5
Atlanta 5
City of London 5
Cotonou 5
Falls Church 5
Guangzhou 5
Hangzhou 5
Hải Dương 5
Lanzhou 5
Lappeenranta 5
Mexico City 5
Osasco 5
Redwood City 5
Rio de Janeiro 5
Taiyuan 5
Washington 5
Auburn Hills 4
Baghdad 4
Boston 4
Guayaquil 4
Haiphong 4
Mumbai 4
Nuremberg 4
Ottawa 4
Piracicaba 4
Totale 3.567
Salva come PNG Salva come JPEG
Nome #
International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients. 282
Ataluren-driven Restoration of Shwachman-Bodian-Diamond Syndrome Protein Function in Shwachman-Diamond Syndrome Bone Marrow Cells 198
Further characterization of Shwachman-Diamond syndrome: psychological functioning and quality of life in adult and young patients. 187
Further Insights into the Hematological Disorders Observed in Shwachman-Diamond Syndrome: mTOR and STAT3 Hyper-Phosphorylation in CD4+ and CD8+ T Cells and Efficacy of Rapamycin Treatment 180
A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass 178
Ataluren improves hematopoietic and pancreatic disorders in Shwachman-Diamond syndrome patients: a compassionate program case-series 177
Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. 176
Evaluation of energy metabolism and calcium homeostasis in cells affected by Shwachman-Diamond syndrome 170
Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. 168
mTOR and STAT3 Pathway Hyper-Activation is Associated with evated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment 168
291 Colon cancer screening program in adult CF patients: an Italian cross-sectional pilot study 163
Identification of novel mutations in patients with Shwachman-Diamond syndrome 162
Absence of acquired copy number neutral loss of heterozygosity (CN-LOH) of chromosome 7 in a series of 10 patients with Shwachman-Diamond syndrome 159
Real-Life Experience with CFTR Modulators Shows Correction of LAD-IV Phenotype in Cystic Fibrosis 156
Optical Measurements of Sweat for in Vivo Quantification of CFTR Function in Individual Sweat Glands 155
Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability. 154
Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman-Diamond syndrome cells 152
A Prospective Study of Hematologic Complications and Long-Term Survival of Italian Patients Affected by Shwachman-Diamond Syndrome 151
A Prospective Haematological Survey Of Italian Patients Affected By Shwachman-Diamond Syndrome: Results Of A Ten Years Multicentric Study 150
Shwachman-Diamond syndrome 145
GENETIC ANALYSIS OF THE SBDS GENE AMONG NON-ITALIAN PATIENTS 145
Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation 134
Peripheral blood immunophenotyping in a large cohort of patients with Shwachman-Diamond syndrome 133
Shwachman-Diamond syndrome with clonal interstitial deletion of the long arm of chromosome 20 in bone marrow: haematological features, prognosis and genomic instability 132
Celiac disease and obesity: need for nutritional follow-up after diagnosis. 130
Constitutive systemic inflammation in Shwachman-Diamond Syndrome 130
Novel Translational Read-Through–Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome 129
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation 128
Mutation Screening of Elongation Factor 2 in Shwachman-Diamond Syndrome Patients Lacking Mutations in the SBDS Gene 127
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 127
Mesenchymal stem cells from Shwachman-Diamond syndrome patients display normal functions and do not contribute to hematological defects 126
Normative growth charts for Shwachman-Diamond syndrome from Italian cohort of 0-8 years old 125
Whole exome sequencing discloses heterozygous variants in the DNAJC21 and EFL1 genes but not in SRP54 in 6 out of 16 patients with Shwachman-Diamond Syndrome carrying biallelic SBDS mutations 112
New insights into the Shwachman-Diamond Syndrome-related haematological disorder: hyper-activation of mTOR and STAT3 in leukocytes 108
Efficacy of Elexacaftor–Tezacaftor–Ivacaftor on chronic rhinosinusitis in cystic fibrosis 100
Development of translational read-through-inducing drugs as novel therapeutic options for patients with Fanconi anemia 97
Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis 89
Structural variation in SBDS gene, with loss of exon 3, in two Shwachman-Diamond patients 87
The Gluten Free Diet's Impact on Growth in Children with Celiac Disease in Two Different Countries 86
Modulation of immune responses by elexacaftor/tezacaftor/ivacaftor therapy in cystic fibrosis: data from a compassionate use program 28
Totale 5.704
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.643
article - articoli 16.293
book - libri 0
conference - conferenze 1.350
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.286
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202155 0 0 0 0 0 0 0 0 0 5 23 27
2021/2022210 11 75 1 11 7 3 4 15 7 6 17 53
2022/2023587 32 81 42 113 48 134 4 32 68 8 15 10
2023/2024307 9 23 21 37 33 47 11 32 7 28 42 17
2024/2025852 34 30 36 164 36 33 44 32 150 38 71 184
2025/20262.756 146 155 314 510 685 176 252 153 209 156 0 0
Totale 5.704